Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
Alzheimer’s disease (AD) is the most common cause of dementia. However, current diagnostic tools are subjective, cost-inefficient, and difficult to administer. Blood-based biomarkers, which are quantitative and non-invasive, have thus been increasingly investigated as potential diagnostic tools. Exp...
Saved in:
Main Author: | Dan Yuet Ruh |
---|---|
Other Authors: | - |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/176360 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Encoding and decoding multimodal brain images for disease biomarker discovery
by: Chan, Yi Hao
Published: (2024) -
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
by: Chua, Xin Ying, et al.
Published: (2021) -
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment
by: Chai, Yuek Ling, et al.
Published: (2021) -
Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
by: Kandiah, Nagaendran, et al.
Published: (2024) -
Brain macrophages in Alzheimer's disease: from ontogeny to function
by: Wu, Xiaoting
Published: (2024)